Follow Neal Boortz on

The world-famous Internet site of the Nationally Syndicated Neal Boortz Show!

Listen: Weekdays 8:30-1pm ET

ChBE Seminar Series–Dr. Michael Dickey

Where

Georgia Institute of Technology
900 Atlantic Dr NW
Atlanta, GA 30318

Upcoming

Wednesday, Feb. 29, 2012

Categories

Events,  On Campus | Alumni

Location: Event DetailsDate/Time: Wednesday March 28, 2012 4:00 pm - 5:00 pm Location: Atlanta, GAPhone: (404) 894-1838 Email: news@chbe.gatech.eduExtras: Free food! Contact: Josie Giles (404) 385-2299 josie@gatech.edu Description: In addition to its annual lectures, ChBE hosts a weekly seminar throughout the year with invited lecturers who are prominent in their fields. Unless otherwise noted, all seminars are held on Wednesdays in the Molecular Science and Engineering Building ("M" Building) in G011 (Cherry Logan Emerson Lecture Theater) at 4:00 p.m. Refreshments are served at 3:30 p.m. in the Emerson-Lewis Reception Salon. Please visit http://chbe.gatech.edu/seminars to view seminar abstract.March 28 Dr. Michael Dickey Assistant Professor Department of Chemical and Biomolecular Engineering North Carolina State University New Approaches for Soft, Stretchable, and Biomimetic ElectronicsRelated Links ChBE Seminar Series Dr. Michael Dickey The School of Chemical & Biomolecular Engineering (ChBE) is one of eight schools in the College of Engineering at the Georgia Institute of Technology. Established in 1901, ChBE is one of the first chemical engineering programs in the country. With 700 undergraduates, 200 graduate students, and more than 40 full-time faculty members, it is also one of the largest. ChBE faculty members are involved in 13 comprehensive areas of education, research, and commercialization with a strategic focus on energy and sustainability, biotechnology, materials and nanotechnology, and complex systems.
 
 

Neal Boortz's Latest Tweets

 
 

© 2013 Cox Media Group. By using this website, you accept the terms of our Visitor Agreement and Privacy Policy, and understand your options regarding Ad ChoicesAdChoices.